Dividend Declaration

RNS Number : 7252P

Hikma Pharmaceuticals Plc

06 October 2011

 



Hikma Pharmaceuticals PLC

Interim Dividend for 2011

LONDON, 6 October 2011 - Hikma Pharmaceuticals PLC ("the Company") advises that, as previously announced with the interim results, the interim dividend of 5.5 cents per will be paid on 13 October 2011 to shareholders on the register on 9 September 2011. 

Shareholders who have elected to receive their dividend in Pounds Sterling will receive 3.555 pence per Ordinary Share (exchange rate US$1.5470 to GBP£1).

Shareholders who have elected to receive their dividend in Jordanian Dinar will receive 7.768 qirsh (piastres) per Ordinary Share (exchange rate US$0.708 to JOD1).

- ENDS -

Enquiries:

Hikma Pharmaceuticals PLC
Henry Knowles Company Secretary	[phone]
Susan Ringdal Investor Relations Director	[phone]

About Hikma

Hikma Pharmaceuticals PLC is a fast growing multinational group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed pharmaceutical products.  Hikma's operations are conducted through three businesses: "Branded", "Injectables" and "Generics".  Hikma's operations are based principally in the Middle East and North Africa ("MENA") region, where it is a market leader and sells across 17 countries, the United States and Europe.  In 2010, the Group achieved revenues of $731 million (2009 $637 million) and profit attributable to shareholders was $99 million (2009 $78 million). 

 

END

 

 

DIVMFBITMBTMBAB